Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzymotec Ltd (NASDAQ:ENZY)

11.45
Delayed Data
As of 2:09pm ET
 +0.20 / +1.78%
Today’s Change
5.20
Today|||52-Week Range
12.35
+74.81%
Year-to-Date
No recent news for Enzymotec Ltd.

Today’s Trading

Previous close11.25
Today’s open11.20
Day’s range11.20 - 11.45
Volume10,710
Average volume (3 months)61,419
Market cap$257.1M
Dividend yield--
Data as of 2:09pm ET, 09/20/2017

Growth & Valuation

Earnings growth (last year)-143.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)-5.35%
P/E ratio--
Price/Sales3.12
Price/Book1.88

Competitors

 Today’s
change
Today’s
% change
CRISCuris Inc+0.01+0.59%
TOCATocagen Inc-0.18-1.42%
VYGRVoyager Therapeutics...+0.38+2.22%
MRUSMerus NV+0.91+5.70%
Data as of 2:40pm ET, 09/20/2017

Financials

Next reporting dateNovember 15, 2017
EPS forecast (this quarter)$0.10
Annual revenue (last year)$47.7M
Annual profit (last year)-$2.9M
Net profit margin-6.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Erez Israeli
Chief Financial Officer &
Vice President
Dror Israel
Corporate headquarters
Migdal HaEmeq, Hazafon

Forecasts